MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    In vivo mapping of nigro-striatal dopamine transporter (DAT) availability in early Parkinson´s disease patients using [18F]FE-PE2I and high-resolution positron emission tomography.

    P. Fazio, P. Svenningsson, Z. Cselenyi, C. Halldin, L. Farde, A. Varrone (Stockholm, Sweden)

    Objective: The objective of the present work was to evaluate in vivo with high resolution positron emission tomography (PET), the relative loss of the dopamine…
  • 2017 International Congress

    Olfactory Impairment in Parkinson’s Disease and White Matter Abnormalities in Central Olfactory Areas

    S. Sobhani, M. Aarabi (Tehran, Islamic Republic of Iran)

    Objective: To determine white matter abnormalities in PD patients with various degrees of olfactory impairment. Background: Neuroimaging results of PD brain based on diffusion tensor…
  • 2017 International Congress

    Pathway Selective Deep Brain Stimulation Derived from Patient-Specific Models

    K. Gunalan, B. Howell, R. Patriat, Y. Duchin, G. Sapiro, N. Harel, C. McIntyre (Cleveland, OH, USA)

    Objective: The goal of this work is to quantify the specific pathways directly activated by clinical DBS settings. Background: Deep brain stimulation (DBS) of the…
  • 2017 International Congress

    Assessment of substantia nigra degeneration with magnetic resonance and transcranial ultrasonography

    C. Prieto, V. Suárez, C. Ordás, B. Venegas, R. Cazorla, A. Vinagre (Valdemoro, Spain)

    Objective: Our objective was to assess both exploration techniques in patients with initial IPD and verify the concordance of the findings, thus positioning them as…
  • 2017 International Congress

    Changes in saccade performance with oculomotor task repetition in neurological disorders

    Y. Terao, H. Fukuda, S.-i. Tokushige, S. Inomata-Terada, Y. Ugawa (Tokyo, Japan)

    Objective: To investigate short-term changes in saccade performance associated with repeated performance of oculomotor tasks in various neurological disorders and to elucidate the underlying neural…
  • 2017 International Congress

    Two ethnic clusters with Huntington’s disease in Israel – The case of Mountain Jews and Karaites

    J. Zitser, A. Thaler, N. Inbar, S. Naor, N. Giladi, T. Gurevich (Tel Aviv, Israel)

    Objective: To Assess frequencies of Huntington disease among different Israeli sub-populations Background: Worldwide prevalence estimates of Huntington's disease (HD) vary widely with no reliable information…
  • 2017 International Congress

    Experience and outcomes of the first Movement Disorders Clinic in Honduras.

    J. Ortiz, A. Medina, F. Naranjo (Tegucigalpa, Honduras)

    Objective: To describe the frequency and clinical characteristics using standardized scales in patients with movement disorders (MD) recruited by a referral system in Tegucigalpa, Honduras.…
  • 2017 International Congress

    Pancreatic polypeptide plasma levels in Parkinson’s disease – a marker of parasympathetic denervation

    K. Knudsen, T. Fedorova, K. Østergaard, P. Borghammer (Aarhus, Denmark)

    Objective: To study plasma PP concentration during sham feeding in PD patients and healthy controls, as a measure of pancreatic vagal innervation. Background: Most patients…
  • 2017 International Congress

    The influence of sleep disordered breathing in REM sleep behavior disorder associated symptoms

    P. Bugalho, M. Mendonça, M. Salavisa, R. Barbosa (Lisbon, Portugal)

    Objective: To compare the intensity of non-motor symptoms between REM sleep behavioral disorder (RBD) patients with and without Obstructive Sleep Apnea (OSA). Background: In RBD…
  • 2017 International Congress

    Speech Markers Estimate Motor Severity and Global Cognition in Parkinson’s Disease

    K. Smith, T. Quatieri, J. Williamson (Worcester, MA, USA)

    Objective: To utilize free speech characteristics to develop markers of motor and cognitive status in Parkinson’s disease (PD). Background: Vocal biomarkers based on speech volume,…
  • « Previous Page
  • 1
  • …
  • 105
  • 106
  • 107
  • 108
  • 109
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley